Delivery Order SPE2DB22D9239-SPE2DB23FDF87
Award Date 1/9/23
Potential Completion Date 1/31/23
Potential Value $115K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the drug Entyvio. The delivery order, valued at $141,773.70, has a completion date of November 21, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles (IDVs) to supply pharmaceuticals and medical products to military treatment facilities...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the pharmaceutical drug Entyvio. The delivery order has a potential value of $144,367.80 and a completion date of May 4, 2023. This award is under a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to provide a variety of pharmaceutical and medical supplies to military treatment facilities...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the pharmaceutical drug Entyvio. The delivery order, valued at $144,367.80, has a completion date of May 30, 2023. This award is part of a larger indefinite delivery contract between DMS Pharmaceutical Group and DLA Troop Support Medical to supply a variety of pharmaceutical and medical supplies, including prescription...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Entyvio 300 mg vials. The order is valued at $96,245.20 and has a performance period through January 17, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple contracts and indefinite delivery vehicles (IDVs) with DLA Troop Support Medical to supply a variety of pharmaceutical and medical products in support of...
- The Defense Logistics Agency (DLA) awarded a $115,494.24 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Entyvio 300 mg vials. This order is being fulfilled under a larger indefinite delivery contract with DMS Pharmaceutical Group to provide a variety of pharmaceutical and medical products to support the operations of military treatment facilities worldwide. The contract does not have a set-aside designation and is...
- The Defense Logistics Agency (DLA) awarded a $14,786.04 firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the pharmaceutical drug Entyvio. This delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceuticals and medical supplies to DLA Troop Support Medical facilities worldwide. DMS Pharmaceutical Group provides a wide range of brand name and generic drugs, as...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Entyvio 300 mg vials. The delivery order, valued at $113,418.96, was issued under an existing indefinite delivery contract with DLA to supply various medical supplies and pharmaceuticals to military treatment facilities worldwide. DMS Pharmaceutical Group holds numerous federal contracts and blanket purchase...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $118,288.32, is for the delivery of Entyvio 300 mg vials. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that runs through December 31, 2025. The IDC allows the DLA to issue delivery orders for a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 milligram vials of Entyvio, a pharmaceutical product, with a potential value of $170,128.44. The delivery order was placed against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply various pharmaceutical items and medical supplies to support military treatment facilities worldwide. The contract does not...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $34,500.76, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to $499,999,999, that allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB23FDF87Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the drug Entyvio. The order has a potential value of $115,494.24 and a completion date of January 31, 2023. This delivery order is part of a larger indefinite delivery contract between DMS Pharmaceutical Group and DLA to supply a variety of pharmaceutical and medical products, including items such as atropine, Narcan nasal spray, and intravenous saline, to support military treatment facilities worldwide. The contract does not have a set-aside designation.
Generated 3/21/24, 11:24 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $115.5k | 1/9/23 |